BioSpace News Archive

ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the William Blair 40 th Annual Growth Stock Conference on Wednesday, June 10, 2020, beginning at approximately 12:00 p.m. (Central Daylight Time) via video webcast. More information about this event, inclu

Portage Biotech Inc. (CSE: PBT.U) (OTC-Markets: PTGEF) (“Portage” or the “Corporation”) wishes to announce that, further to its news release dated May 25, 2020 , the Corporation’s common shares will commence trading on a one hundred (100) old for one (1) new share consolidated basis (the “Consolidation”) (also kn

Noble services offered by caregivers from around the world continue to nurture the fragile health of elderlies as well as the blooming lives of infants. Demand for health caregiving services will continue to surge in the years to come as people will keep appointing professional help for nursing the health of their loved ones.

Understanding various aspects of the hip resurfacing implants market, Persistence Market Research has put forth an in-depth research analysis on the global market for hip resurfacing implants in a cohesive manner in its latest publication titled “Hip Resurfacing Implants Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025).

Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, today announced that it will host a virtual analyst event to discuss Principia’s unique precision bonding technology platform,

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that Lyndah K. Dreiling, M.D., MBA, has been named Senior Vice President, Clinical Development. “

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40th Annual William Blair Growth Stock Conference.

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at the William Blair 40th Annual Growth Stock Conference (virtual) on Wednesday, June 10, 2020 at 1:20pm CT.

Abrocitinib met all key endpoints, demonstrating statistically superior improvements in skin clearance, disease extent and severity, and itch compared to placebo